1. Ribociclib plus letrozole provides significant overall survival benefit as compared to letrozole alone in patients with advanced breast cancer. ...
1. A randomized controlled trial of 85 participants found no significant difference in vaginal symptom severity after 12 months between ...
1. A five-year extension of anastrozole treatment was shown not to provide additional benefit compared to a two-year extension in ...
Click to read the study in The Lancet Oncology.
1. In this randomized, controlled trial of healthy menopausal women, hormonal therapy did not slow the progression of atherosclerosis. 2. ...
Image: PD 1. Romosozumab, an anti-sclerostin antibody, significantly increased bone mineral density in postmenopausal women compared to placebo. 2. When ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. Compared to oral estradiol use, oral conjugated equine estrogen (CEE) use was associated with an increased incidence ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.